Copyright
©The Author(s) 2015.
World J Gastroenterol. Sep 28, 2015; 21(36): 10443-10452
Published online Sep 28, 2015. doi: 10.3748/wjg.v21.i36.10443
Published online Sep 28, 2015. doi: 10.3748/wjg.v21.i36.10443
Figure 3 Comparison of the median progression free survival in patients with different BCLC stages and patient state in the chemoembolization + hepatic arterial infusion chemotherapy treatment group (group B) and chemoembolization alone treatment group (group A).
A: Hepatocellular carcinoma (HCC) patients with BCLC stage A/B disease; B: HCC patients with BCLC stage C disease; C: HCC patients without vessel invasion; D: HCC patients with vessel invasion. HAIC: Hepatic arterial infusion chemotherapy.
-
Citation: Gao S, Zhang PJ, Guo JH, Chen H, Xu HF, Liu P, Yang RJ, Zhu X. Chemoembolization alone
vs combined chemoembolization and hepatic arterial infusion chemotherapy in inoperable hepatocellular carcinoma patients. World J Gastroenterol 2015; 21(36): 10443-10452 - URL: https://www.wjgnet.com/1007-9327/full/v21/i36/10443.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i36.10443